The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
ARL6 (UniProt: Q9H0F7) encodes ADP-ribosylation factor-like protein 6, also known as Bardet-Biedl syndrome 3 protein (BBS3), in Homo sapiens (singh2020structureandactivation pages 1-2, wingfield2018traffickingofciliary pages 1-2). This protein belongs to the small GTPase superfamily, specifically the ARF family, confirming alignment with the provided UniProt annotation (fisher2020arffamilygtpases pages 1-5). The gene symbol ARL6 is consistently used in the literature and corresponds to the correct human protein involved in ciliary function and Bardet-Biedl syndrome.
ARL6 functions as a small GTP-binding protein with intrinsic GTPase activity, operating as a molecular switch that cycles between GDP-bound (inactive) and GTP-bound (active) states (singh2020structureandactivation pages 2-3, fisher2020arffamilygtpases pages 1-5). The protein's primary biochemical activity is not the catalysis of metabolic substrates, but rather the binding and hydrolysis of GTP to regulate protein-protein interactions and membrane recruitment (fisher2020arffamilygtpases pages 1-5, chiuso2023ubiquitylationofbbsome pages 1-2).
The GTP-bound form of ARL6 represents the functionally active state. Structural studies using electron cryomicroscopy (cryo-EM) at 3.5 Å resolution demonstrated that the BBSome interacts exclusively with the GTP-bound form of ARL6, not the GDP-bound form (singh2020structureandactivation pages 2-3). This nucleotide-dependent specificity is essential for ARL6's regulatory function in ciliary trafficking.
The primary function of ARL6 is to recruit the BBSome, an octameric protein complex, to ciliary membranes (singh2020structureandactivation pages 1-2, chiuso2023ubiquitylationofbbsome pages 1-2, chou2019themoleculararchitecture pages 1-3). This recruitment is mediated by ARL6:GTP binding to a composite interface formed by the β-propeller domains of BBS1 and BBS7 within the BBSome (singh2020structureandactivation pages 1-2, singh2020structureandactivation pages 2-3, singh2020structureandactivation pages 3-5).
High-resolution structural analyses revealed that BBSome activation requires an unexpected conformational change. In solution, the BBSome exists in an autoinhibited closed state where the ARL6-binding site is occluded (singh2020structureandactivation pages 1-2, chou2019themoleculararchitecture pages 1-3). Activation requires swiveling of the β-propeller domain of BBS1, which widens a central cavity of the BBSome and exposes the composite binding site for ARL6 (singh2020structureandactivation pages 1-2, singh2020structureandactivation pages 3-5). This structural rearrangement is critical for ARL6 to bind and recruit the BBSome to membranes.
The ARL6-BBS1 interaction is reinforced by BBS9, another BBSome subunit, which strengthens the binding interface within the intact BBSome core (nozaki2018bbs1isinvolved pages 1-2, chiuso2023ubiquitylationofbbsome pages 1-2). Studies in BBS1-knockout cells demonstrated that loss of BBS1 prevents ciliary entry of other BBSome subunits and ARL6, confirming the integral nature of this interaction for complex assembly and function (nozaki2018bbs1isinvolved pages 1-2).
As a member of the ARF family, ARL6 possesses an amphipathic N-terminal helix that associates with membranes in a GTP-dependent manner (singh2020structureandactivation pages 1-2). This property allows ARL6:GTP to anchor the BBSome to ciliary membranes, enabling the BBSome to function as a coat-like adaptor for membrane protein trafficking (chou2019themoleculararchitecture pages 1-3, wingfield2018traffickingofciliary pages 1-2).
ARL6 localizes specifically to the primary cilium, ciliary membrane, and basal body (singh2020structureandactivation pages 1-2, chiuso2023ubiquitylationofbbsome pages 1-2, tian2023organizationfunctionsand pages 1-2, melluso2023bardetbiedlsyndromecurrent pages 1-3). It is described as a cilium-specific member of the ARF family GTPases (singh2020structureandactivation pages 1-2). The protein concentrates at the ciliary base and within ciliary trafficking routes, where it performs its function in recruiting the BBSome to facilitate protein transport across the transition zone—a diffusion barrier that separates the ciliary from the plasma membrane (chou2019themoleculararchitecture pages 1-3, wingfield2018traffickingofciliary pages 1-2).
Studies using immunofluorescence and cell biological approaches consistently demonstrate ARL6's enrichment in ciliary compartments, particularly at the basal body where BBSome recruitment initiates (tian2023organizationfunctionsand pages 1-2, chiuso2023ubiquitylationofbbsome pages 1-2). The ciliary localization is essential for ARL6's role in coordinating membrane protein trafficking into and out of the cilium.
ARL6 functions as a central regulator of ciliary membrane protein trafficking (chou2019themoleculararchitecture pages 1-3, wingfield2018traffickingofciliary pages 1-2, singh2020structureandactivation pages 1-2). The protein operates within a sophisticated pathway that controls which membrane proteins enter and exit the cilium, thereby maintaining the unique composition of the ciliary membrane.
The mechanistic pathway proceeds as follows: ARL6:GTP recruits the BBSome to the ciliary base and ciliary membranes (chiuso2023ubiquitylationofbbsome pages 1-2, chou2019themoleculararchitecture pages 1-3). The BBSome then functions as an adaptor complex that recognizes specific cargo proteins, including G-protein-coupled receptors (GPCRs) and other transmembrane proteins (wingfield2018traffickingofciliary pages 1-2, chou2019themoleculararchitecture pages 1-3). The BBSome-cargo complex associates with intraflagellar transport (IFT) trains—comprised of IFT-A and IFT-B complexes along with molecular motors—which mediate bidirectional transport along the ciliary microtubule axoneme (chiuso2023ubiquitylationofbbsome pages 1-2, wingfield2018traffickingofciliary pages 1-2, chou2019themoleculararchitecture pages 1-3).
Recent evidence indicates that the BBSome primarily functions in removing proteins from cilia rather than importing them (singh2020structureandactivation pages 1-2, chou2019themoleculararchitecture pages 1-3). The BBSome promotes retrieval and export of specific transmembrane proteins from the cilium, with the IFT-A complex mediating entry (singh2020structureandactivation pages 1-2). This export function is critical for the signal-dependent exit of ciliary GPCRs and for preventing accumulation of proteins not normally destined for cilia (singh2020structureandactivation pages 1-2).
ARL6-dependent BBSome function is essential for proper trafficking of multiple GPCRs and signaling receptors in cilia. Specific cargoes identified include Smoothened (SMO), GPR161, and somatostatin receptor 3 (SSTR3) (nozaki2018bbs1isinvolved pages 1-2, shinde2020ubiquitinchainsearmark pages 1-1, singh2020structureandactivation pages 1-2). In cells lacking functional BBS1 (a key ARL6-binding partner), these GPCRs show defects in ciliary retrograde trafficking and export (nozaki2018bbs1isinvolved pages 1-2).
Recent work from 2020 demonstrated that upon GPCR activation, receptors become tagged with K63-linked ubiquitin chains in a β-arrestin-dependent manner, and this ubiquitination marks the GPCRs for BBSome-mediated removal from cilia (shinde2020ubiquitinchainsearmark pages 1-1). The BBSome/ARL6 system is required for this signal-dependent exit mechanism (shinde2020ubiquitinchainsearmark pages 1-1).
Through its control of GPCR trafficking, ARL6 indirectly regulates the Hedgehog (Hh) signaling pathway, which relies on dynamic changes in ciliary receptor localization (tian2023organizationfunctionsand pages 1-2, chiuso2023ubiquitylationofbbsome pages 1-2, wingfield2018traffickingofciliary pages 1-2). During Hh signaling, GPR161 must exit cilia while SMO accumulates within cilia (chou2019themoleculararchitecture pages 1-3). Disruption of ARL6 or BBSome function leads to ciliary mislocalization of these receptors, causing abnormal Hedgehog signal transduction (tian2023organizationfunctionsand pages 1-2, chiuso2023ubiquitylationofbbsome pages 1-2).
Studies using BBS1 mutants lacking BBS9-binding ability demonstrated impaired trafficking of SMO and GPR161, resulting in defects in Shh-dependent gene transcription (nozaki2018bbs1isinvolved pages 1-2, chiuso2023ubiquitylationofbbsome pages 1-2). This establishes that the intact BBSome, properly recruited by ARL6, is required for Hedgehog pathway regulation.
Recent research from 2023 identified a novel regulatory mechanism involving ubiquitylation. The E3 ubiquitin ligase PJA2 localizes to the ciliary compartment and ubiquitylates BBSome subunits upon GPCR-cAMP stimulation (chiuso2023ubiquitylationofbbsome pages 1-2). Specifically, ubiquitylation of BBS1 at lysine 143 increases BBSome stability and promotes its binding to BBS3/ARL6, thereby enhancing trafficking to the ciliary membrane (chiuso2023ubiquitylationofbbsome pages 1-2). Expression of a ubiquitylation-defective BBS1 mutant (BBS1K143R) impairs GPCR trafficking and Shh-dependent gene transcription, demonstrating functional significance (chiuso2023ubiquitylationofbbsome pages 1-2).
Despite extensive characterization of ARL6 function, the guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs) that regulate ARL6 remain incompletely defined (fisher2020arffamilygtpases pages 1-5). Reviews of ARF family GTPases emphasize that identification of the GEFs and GAPs for ARL6 represents a key knowledge gap and an important area for future research (fisher2020arffamilygtpases pages 1-5). Understanding these regulators would provide deeper insight into how ARL6 activation is controlled spatially and temporally within cilia.
Mutations in ARL6 cause Bardet-Biedl syndrome type 3 (BBS3), an autosomal recessive ciliopathy characterized by multisystem manifestations (melluso2023bardetbiedlsyndromecurrent pages 1-3, dollfus2024bardetbiedlsyndromeimproved pages 1-2, wingfield2018traffickingofciliary pages 1-2). The core clinical features of BBS include:
Importantly, BBS3/ARL6 deficiency shows genotype-phenotype variability. Recent consensus statements from 2024 note that patients with mutations in BBS3/ARL6 have a significantly lower syndromic score and lower penetrance of kidney anomalies compared to patients with mutations in other BBS genes (dollfus2024bardetbiedlsyndromeimproved pages 1-2, melluso2023bardetbiedlsyndromecurrent pages 1-3). This suggests that ARL6 dysfunction may produce a somewhat milder or more variable phenotype than mutations affecting BBSome structural subunits or chaperonins.
The pathogenesis of BBS features results from impaired ciliary trafficking and consequent ciliary dysfunction (tian2023organizationfunctionsand pages 1-2, melluso2023bardetbiedlsyndromecurrent pages 1-3). Structural mapping of disease-causing mutations suggests that pathogenesis predominantly results from disruption of autoinhibition and activation of the BBSome, folding defects, or altered ARL6-BBSome interactions (singh2020structureandactivation pages 1-2).
In retinal photoreceptors, which possess highly specialized cilia called outer segments, ARL6/BBSome dysfunction causes rhodopsin localization defects and photoreceptor apoptosis, contributing to retinal degeneration (tian2023organizationfunctionsand pages 1-2, delvallee2023retinaldegenerationanimal pages 1-2). Obesity in BBS can be explained by mislocalization of receptors such as neuropeptide Y receptor, serotonin receptor, and leptin receptor in hypothalamic neuronal cilia, leading to hyperphagia (tian2023organizationfunctionsand pages 1-2). Polydactyly results from loss of Hedgehog signaling components from cilia, causing embryonic developmental defects (tian2023organizationfunctionsand pages 1-2).
In 2024, four European Reference Networks (ERN-EYE, ERKNet, Endo-ERN, ERN-ITHACA) published revised diagnostic criteria for BBS that incorporate molecular diagnosis alongside clinical features (dollfus2024bardetbiedlsyndromeimproved pages 1-2). The updated criteria take into account the age of the patient and emphasize that genetic testing has progressively improved, prompting revision of purely clinical diagnostic approaches (dollfus2024bardetbiedlsyndromeimproved pages 1-2). These guidelines provide a framework for initial diagnosis, lifelong monitoring, and symptomatic management of BBS patients (dollfus2024bardetbiedlsyndromeimproved pages 1-2).
Current management remains supportive, as there is no cure for BBS (melluso2023bardetbiedlsyndromecurrent pages 1-3, dollfus2024bardetbiedlsyndromeimproved pages 1-2). Patients benefit from multidisciplinary intervention including visual services, physical therapy, endocrinological management of obesity and metabolic complications, and renal monitoring to detect and manage chronic kidney disease (melluso2023bardetbiedlsyndromecurrent pages 1-3, dollfus2024bardetbiedlsyndromeimproved pages 1-2). Recent advances include better evaluation of eating behavior problems, improved lifestyle programs, and novel pharmacological therapies for obesity management in BBS (dollfus2024bardetbiedlsyndromeimproved pages 1-2).
| Category | ARL6-specific finding | Key details | Evidence |
|---|---|---|---|
| Protein identity | ARL6 encodes ADP-ribosylation factor-like protein 6 and is also called BBS3 | ARL6/BBS3 is a member of the ARF/ARL small GTPase family and is part of the conserved core BBS machinery linked to cilia and Bardet-Biedl syndrome | (singh2020structureandactivation pages 1-2, wingfield2018traffickingofciliary pages 1-2, fisher2020arffamilygtpases pages 1-5) |
| Molecular function as a GTPase | Small ARF-like GTP-binding protein with intrinsic GTPase activity | Functions as a nucleotide-dependent molecular switch; the GTP-bound form is the functionally relevant state for BBSome recruitment, and ARL6 has been described as having intrinsic GTPase activity in recent mechanistic work | (singh2020structureandactivation pages 2-3, chiuso2023ubiquitylationofbbsome pages 1-2, fisher2020arffamilygtpases pages 1-5) |
| Primary biochemical role | Recruits the BBSome to membranes/cilia | ARL6:GTP binds the BBSome and promotes its targeting to the basal body/ciliary membrane, a prerequisite for BBSome-dependent trafficking across the transition zone | (singh2020structureandactivation pages 1-2, chiuso2023ubiquitylationofbbsome pages 1-2, chou2019themoleculararchitecture pages 1-3) |
| Structural mechanism | ARL6 recognizes a composite BBSome binding site | Cryo-EM work showed that ARL6 binds an active BBSome conformation, contacting a site formed by BBS1 and BBS7; BBS1 β-propeller movement is required to expose this site | (singh2020structureandactivation pages 1-2, singh2020structureandactivation pages 2-3, singh2020structureandactivation pages 3-5) |
| Substrate/nucleotide specificity | Prefers/acts through GTP-bound state rather than GDP-bound state | The BBSome interacts with only the GTP-bound form of ARL6 in the structural purification/reconstitution studies, indicating nucleotide-state specificity for effector engagement | (singh2020structureandactivation pages 2-3) |
| Enzymatic interpretation | Not a metabolic enzyme; its key “substrate” is guanine nucleotide cycling | For this protein, the relevant biochemical activity is binding and hydrolysis of GTP to regulate effector recruitment rather than catalysis of a small-molecule transformation | (fisher2020arffamilygtpases pages 1-5, chiuso2023ubiquitylationofbbsome pages 1-2) |
| Subcellular localization | Primary cilium, ciliary membrane, and basal body/ciliary base | Reviews and primary studies place ARL6 at the ciliary compartment, where it helps recruit the BBSome; BBS-related proteins are concentrated at the ciliary base and within ciliary trafficking routes | (singh2020structureandactivation pages 1-2, chiuso2023ubiquitylationofbbsome pages 1-2, tian2023organizationfunctionsand pages 1-2, melluso2023bardetbiedlsyndromecurrent pages 1-3) |
| Membrane association | Associates with membranes in a GTP-dependent manner | As an Arf-family GTPase with an amphipathic N-terminus, ARL6 is described as associating with membranes when GTP-bound, consistent with its role in docking trafficking machinery to ciliary membranes | (singh2020structureandactivation pages 1-2) |
| Principal binding partners/effectors | BBSome, especially BBS1 and BBS7; BBS1 interaction reinforced by BBS9 | ARL6 directly binds the BBSome through BBS1-containing interfaces; cell and biochemical work indicates that BBS9 strengthens the ARL6–BBS1 interaction within the intact BBSome core | (singh2020structureandactivation pages 1-2, nozaki2018bbs1isinvolved pages 1-2, chiuso2023ubiquitylationofbbsome pages 1-2) |
| Functional relationship to IFT | Works with IFT/BBSome trafficking machinery | ARL6 enables BBSome loading/recruitment so the BBSome can function as an adaptor linking membrane cargoes to intraflagellar transport for ciliary trafficking and exit | (chiuso2023ubiquitylationofbbsome pages 1-2, wingfield2018traffickingofciliary pages 1-2, chou2019themoleculararchitecture pages 1-3) |
| Role in pathway | Central regulator of ciliary membrane protein trafficking | ARL6 is required for proper movement of signaling receptors and other membrane proteins through the ciliary compartment, especially at the transition zone and during cargo export/removal | (chou2019themoleculararchitecture pages 1-3, wingfield2018traffickingofciliary pages 1-2, singh2020structureandactivation pages 1-2) |
| Cargo/processes influenced | Supports trafficking of GPCRs and other ciliary membrane proteins | BBSome/ARL6 function is linked to the trafficking or removal of receptors such as Smoothened, GPR161, SSTR3, and other ciliary membrane proteins; defects cause receptor mislocalization | (nozaki2018bbs1isinvolved pages 1-2, shinde2020ubiquitinchainsearmark pages 1-1, singh2020structureandactivation pages 1-2) |
| Signaling pathways impacted | Modulates Hedgehog and broader cilium-dependent signaling | Because ARL6 drives BBSome-dependent receptor trafficking, it indirectly controls signaling outputs that depend on receptor localization in cilia, including Shh/Hedgehog and GPCR signaling | (tian2023organizationfunctionsand pages 1-2, chiuso2023ubiquitylationofbbsome pages 1-2, wingfield2018traffickingofciliary pages 1-2) |
| Regulation noted in recent work | BBSome–ARL6 interaction can be enhanced by BBS1 ubiquitylation | A 2023 study reported that ubiquitylation of BBS1 K143 increases BBSome stability and promotes binding to BBS3/ARL6, linking post-translational regulation to ARL6-dependent trafficking | (chiuso2023ubiquitylationofbbsome pages 1-2) |
| Current unknowns | Upstream GEF/GAP regulators for ARL6 remain incompletely defined | Reviews emphasize that, unlike some other ciliary ARLs, the dedicated regulators that activate/inactivate ARL6 are still not well established and remain a key knowledge gap | (fisher2020arffamilygtpases pages 1-5) |
| Disease association | Bardet-Biedl syndrome type 3 (BBS3) | ARL6 mutations cause a ciliopathy with multisystem manifestations; ARL6/BBS3 is one of the established BBS genes and belongs to the non-motile ciliopathy spectrum | (melluso2023bardetbiedlsyndromecurrent pages 1-3, dollfus2024bardetbiedlsyndromeimproved pages 1-2, wingfield2018traffickingofciliary pages 1-2) |
| Disease features linked to ARL6 dysfunction | Retinal degeneration, obesity, polydactyly, renal/genitourinary anomalies, learning/neurodevelopmental issues | These are core BBS features described across recent reviews and consensus guidance; ARL6 defects impair ciliary trafficking, providing the mechanistic basis for the phenotype spectrum | (melluso2023bardetbiedlsyndromecurrent pages 1-3, dollfus2024bardetbiedlsyndromeimproved pages 1-2, tian2023organizationfunctionsand pages 1-2) |
| Clinical nuance | ARL6 deficiency may show lower penetrance of some features, including kidney anomalies, than some other BBS genotypes | Recent reviews/consensus statements note genotype-phenotype variability and specifically mention comparatively lower penetrance of renal manifestations in BBS3/ARL6 deficiency | (dollfus2024bardetbiedlsyndromeimproved pages 1-2, melluso2023bardetbiedlsyndromecurrent pages 1-3) |
Table: This table summarizes the verified identity, molecular function, localization, interacting partners, pathway role, and disease relevance of human ARL6/BBS3. It is useful as a compact evidence map for understanding ARL6 as a ciliary ARF-like GTPase that recruits the BBSome and whose disruption causes Bardet-Biedl syndrome.
ARL6 (BBS3) is a cilium-specific small GTPase that functions as the master regulator for recruitment of the BBSome to ciliary membranes. In its GTP-bound active state, ARL6 binds a composite interface on the BBSome formed by BBS1 and BBS7, triggering a conformational change that activates the BBSome for membrane protein trafficking. The ARL6-BBSome system controls the ciliary trafficking of GPCRs and other membrane proteins, particularly mediating their export from cilia. This function is essential for proper Hedgehog signaling and other cilium-dependent signaling pathways.
Mutations in ARL6 cause Bardet-Biedl syndrome type 3, a multisystem ciliopathy characterized by retinal degeneration, obesity, polydactyly, renal defects, and neurodevelopmental abnormalities. The disease arises from defective ciliary protein trafficking leading to receptor mislocalization and impaired ciliary signaling. Recent clinical developments include updated diagnostic criteria and management guidelines published in 2023-2024.
Future research priorities include identification of the GEF and GAP regulators of ARL6, further characterization of post-translational modifications regulating the ARL6-BBSome interaction, and development of therapeutic strategies targeting the ciliary trafficking pathway for treatment of BBS and related ciliopathies.
References
(singh2020structureandactivation pages 1-2): Sandeep K Singh, Miao Gui, Fujiet Koh, Matthew CJ Yip, and Alan Brown. Structure and activation mechanism of the bbsome membrane protein trafficking complex. Jan 2020. URL: https://doi.org/10.7554/elife.53322, doi:10.7554/elife.53322. This article has 105 citations and is from a domain leading peer-reviewed journal.
(wingfield2018traffickingofciliary pages 1-2): Jenna L. Wingfield, Karl-Ferdinand Lechtreck, and Esben Lorentzen. Trafficking of ciliary membrane proteins by the intraflagellar transport/bbsome machinery. Essays in biochemistry, 62 6:753-763, Oct 2018. URL: https://doi.org/10.1042/ebc20180030, doi:10.1042/ebc20180030. This article has 183 citations and is from a peer-reviewed journal.
(fisher2020arffamilygtpases pages 1-5): Skylar Fisher, Damian Kuna, Tamara Caspary, Richard A. Kahn, and Elizabeth Sztul. Arf family gtpases with links to cilia. American Journal of Physiology-Cell Physiology, 319:C404-C418, Aug 2020. URL: https://doi.org/10.1152/ajpcell.00188.2020, doi:10.1152/ajpcell.00188.2020. This article has 44 citations.
(singh2020structureandactivation pages 2-3): Sandeep K Singh, Miao Gui, Fujiet Koh, Matthew CJ Yip, and Alan Brown. Structure and activation mechanism of the bbsome membrane protein trafficking complex. Jan 2020. URL: https://doi.org/10.7554/elife.53322, doi:10.7554/elife.53322. This article has 105 citations and is from a domain leading peer-reviewed journal.
(chiuso2023ubiquitylationofbbsome pages 1-2): Francesco Chiuso, Rossella delle Donne, Giuliana Giamundo, Laura Rinaldi, Domenica Borzacchiello, Federica Moraca, Daniela Intartaglia, Rosa Iannucci, Emanuela Senatore, Luca Lignitto, Corrado Garbi, Paolo Conflitti, Bruno Catalanotti, Ivan Conte, and Antonio Feliciello. Ubiquitylation of bbsome is required for ciliary assembly and signaling. EMBO Reports, Feb 2023. URL: https://doi.org/10.15252/embr.202255571, doi:10.15252/embr.202255571. This article has 19 citations and is from a highest quality peer-reviewed journal.
(chou2019themoleculararchitecture pages 1-3): Hui-Ting Chou, Luise Apelt, Daniel P. Farrell, Susan Roehl White, Jonathan Woodsmith, Vladimir Svetlov, Jaclyn S. Goldstein, Andrew R. Nager, Zixuan Li, Jean Muller, Hélène Dollfus, Evgeny Nudler, Ulrich Stelzl, Frank DiMaio, Maxence V. Nachury, and Thomas Walz. The molecular architecture of native bbsome obtained by an integrated structural approach. Structure, 27:1384-1394.e4, Sep 2019. URL: https://doi.org/10.1016/j.str.2019.06.006, doi:10.1016/j.str.2019.06.006. This article has 73 citations and is from a domain leading peer-reviewed journal.
(singh2020structureandactivation pages 3-5): Sandeep K Singh, Miao Gui, Fujiet Koh, Matthew CJ Yip, and Alan Brown. Structure and activation mechanism of the bbsome membrane protein trafficking complex. Jan 2020. URL: https://doi.org/10.7554/elife.53322, doi:10.7554/elife.53322. This article has 105 citations and is from a domain leading peer-reviewed journal.
(nozaki2018bbs1isinvolved pages 1-2): Shohei Nozaki, Yohei Katoh, Takuya Kobayashi, and Kazuhisa Nakayama. Bbs1 is involved in retrograde trafficking of ciliary gpcrs in the context of the bbsome complex. PLoS ONE, 13:e0195005, Mar 2018. URL: https://doi.org/10.1371/journal.pone.0195005, doi:10.1371/journal.pone.0195005. This article has 75 citations and is from a peer-reviewed journal.
(tian2023organizationfunctionsand pages 1-2): Xiaoyu Tian, Huijie Zhao, and Jun Zhou. Organization, functions, and mechanisms of the bbsome in development, ciliopathies, and beyond. eLife, Jul 2023. URL: https://doi.org/10.7554/elife.87623, doi:10.7554/elife.87623. This article has 84 citations and is from a domain leading peer-reviewed journal.
(melluso2023bardetbiedlsyndromecurrent pages 1-3): Andrea Melluso, Floriana Secondulfo, Giovanna Capolongo, Giovambattista Capasso, and Miriam Zacchia. Bardet-biedl syndrome: current perspectives and clinical outlook. Therapeutics and Clinical Risk Management, 19:115-132, Jan 2023. URL: https://doi.org/10.2147/tcrm.s338653, doi:10.2147/tcrm.s338653. This article has 107 citations and is from a peer-reviewed journal.
(shinde2020ubiquitinchainsearmark pages 1-1): Swapnil Rohidas Shinde, Andrew R. Nager, and Maxence V. Nachury. Ubiquitin chains earmark gpcrs for bbsome-mediated removal from cilia. The Journal of Cell Biology, Nov 2020. URL: https://doi.org/10.1083/jcb.202003020, doi:10.1083/jcb.202003020. This article has 100 citations.
(dollfus2024bardetbiedlsyndromeimproved pages 1-2): Hélène Dollfus, Marc R. Lilien, Pietro Maffei, Alain Verloes, Jean Muller, Giacomo M. Bacci, Metin Cetiner, Erica L. T. van den Akker, Monika Grudzinska Pechhacker, Francesco Testa, Didier Lacombe, Marijn F. Stokman, Francesca Simonelli, Aurélie Gouronc, Amélie Gavard, Mieke M. van Haelst, Jens Koenig, Sylvie Rossignol, Carsten Bergmann, Miriam Zacchia, Bart P. Leroy, Héléna Mosbah, Albertien M. Van Eerde, Djalila Mekahli, Aude Servais, Christine Poitou, and Diana Valverde. Bardet-biedl syndrome improved diagnosis criteria and management: inter european reference networks consensus statement and recommendations. European Journal of Human Genetics, 32:1347-1360, Jul 2024. URL: https://doi.org/10.1038/s41431-024-01634-7, doi:10.1038/s41431-024-01634-7. This article has 79 citations and is from a domain leading peer-reviewed journal.
(delvallee2023retinaldegenerationanimal pages 1-2): Clarisse Delvallée and Hélène Dollfus. Retinal degeneration animal models in bardet-biedl syndrome and related ciliopathies. Cold Spring Harbor perspectives in medicine, 13 1:a041303, Jan 2023. URL: https://doi.org/10.1101/cshperspect.a041303, doi:10.1101/cshperspect.a041303. This article has 15 citations and is from a peer-reviewed journal.